Is Big Pharma's Next Target Already in Play?
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
Shares Stats
| Shares Outstanding | 81,000,000 |
| Shares Float | 80,450,000 |
| Shares Short | 1,460,000 |
| Insider Holdings | 61% |
| Institution Holdings | 85.13% |
About Globe Life Inc
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates through three segments: Life Insurance, Supplemental Health Insurance, and Investments. It offers whole, term, and other life insurance products; and Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products. The company sells its products through its direct-to-consumer division, exclusive agencies, and independent agents. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
General
| Name | Globe Life Inc |
| Ticker | GL |
| Exchange | NYSE |
| Sector | Financial |
| Industry | Insurance - Life |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 3,732 |
Highlights
| Analyst Target | 166.42 |
| Market Cap | 10,804,300,000 |
| PE Ratio | 9.66 |
| EBITDA | 1,613,680,000 |
Financials
| Curr Year EPS Estimate | 14.56 |
| Next Quarter EPS Estimate | 3.54 |
| Profit Margin | 19.36% |
| Operating Margin | 26.92 |
| Return on Assets | 0.03 |
| Return on Equity | 0.22 |
| Revenue | 5.9B |
| Earnings Per Share | 14.07 |
| Revenue Per Share | 72.01 |
| Gross Profit | 2,026,852,992 |
| Quarterly Revenue Growth | 0.04 |
Valuation
| Trailing PE | 9.48 |
| Forward PE | 10.44 |
| Price/Sales (Trailing 12 Mt.) | 1.82 |
| Price/Book (Most Recent Quarter) | 2.08 |
Dividend
Globe Life Inc pays out a dividend of $1.07 per share, with a dividend yield of 0.81%.
GL's last dividend payment was made to shareholders on October 31, 2025.
They pay out 8.04% of their earnings out as a dividend.
Recent Dividends
| Oct 31, 2025 | $0.27 |
| Aug 1, 2025 | $0.27 |
| May 1, 2025 | $0.27 |
| Jan 31, 2025 | $0.24 |
| Nov 1, 2024 | $0.24 |
| Aug 1, 2024 | $0.24 |
| May 1, 2024 | $0.24 |
| Feb 1, 2024 | $0.23 |
Five 2026 vehicles you should absolutely wait for
Don’t buy that new car yet. If you can wait, you’ll have new 2026 model year options that aren’t out yet. Although some models barely change, others are completely redesigned and often get the latest features and improvements. Whether you’re interested in improved fuel economy, cutting-edge technology, or maybe just fresh and distinctive styling, there’s likely a car on the horizon that you’ll be interested in. To ensure you don’t miss out on the latest and greatest, the car experts at Edmunds highlight five vehicles you should consider waiting for.
Gold prices have tumbled from recent records. What's behind the losses?
NEW YORK (AP) — Less than a day after to another record high, prices for the precious metal plunged — marking the biggest sell-off in years.
Urgent Copper Stock With Strong Catalysts - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Warren Buffett's Berkshire Hathaway Bets Big On Consumer Brands Amid Economic Shifts
Warren Buffett and his successor Greg Abel have been directing Berkshire Hathaway towards consumer-centric investments throughout 2025.
Jim Cramer Warns 'Don't Be Fooled' Because Speculators In Gold, Quantum And Nuclear Energy Aren't Going Down 'Without A Fight'
Former hedge fund manager and renowned CNBC TV host Jim Cramer is sounding the alarm on certain speculative pockets of the market, urging investors to sell into the "snapback" momentum if they haven't already done so.
From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.
Gold Deals Pick Up As Metal Soars Past $4,200
Gold reaches new highs, expected to continue rallying into 2026. Multiple mergers and acquisitions in gold market.
Instacart Powers Grubhub's Grocery Blitz Across America
Grubhub taps Instacart for nationwide grocery ordering, with Instacart fulfillment, pharmacy additions coming, and promos boosting adoption despite CART dip.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Microsoft's quarterly sales and profit surge, beating Wall Street expectations
REDMOND, Wash. (AP) — Microsoft on Wednesday reported its quarterly sales grew 18% to $77.7 billion.
China May Have Made A Breakthrough With Solid State Batteries Offering 600-Mile+ Range, Here's What You Should Know
Chinese researchers' share breakthrough in EV battery technology with solid-state batteries offering 600+ mile range and weighing 220 lbs.
A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
OpenAI's ChatGPT To Allow Erotica For Adults: Not 'Moral Police Of The World,' Sam Altman Says
OpenAI will begin allowing erotica and adult-themed content on ChatGPT, marking a major shift in the company's content policy.
Trump says a Canadian ad misstated Ronald Reagan's views on tariffs. Here are the facts and context
WASHINGTON (AP) — President Donald Trump pulled out of trade talks with Canada Thursday night, furious over what he called a “fake’’ television ad from Ontario’s provincial government that quoted former U.S. President Ronald Reagan from 38 years ago criticizing tariffs -- Trump’s favorite economic tool.
Gold Bars Are Pouring, but This Miner is Still Priced Like a Startup - Ad
You'd expect a gold miner with production, a full refinery, and big-name investors to be trading at a premium. But this one? It's still under $1
Trump Warns Supreme Court Tariff Ruling Could 'Literally Destroy' The US: 'We'll Be Struggling For Years'
President Donald Trump warned that the U.S. economy would face significant challenges if the Supreme Court rules against the majority of the tariffs imposed this year.
Why D-Wave Quantum (QBTS) Stock Is Getting Hammered Today
Shares of D-Wave Quantum are trading lower Wednesday afternoon, caught in a broader market downturn.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
Maye Musk Says She Only 'Lasted' Until 11 PM At Elon's Saturday Meetings, Agrees With Trump's AI Czar No One Works Harder Than Her Son
Maye Musk shares insights into Elon Musk's work habits, emphasizing his dedication. She could only last until 11 PM in his Saturday meetings.
Why Did Dragonfly Energy Shares Jump Over 6% After Hours?
Dragonfly Energy Holdings' stock climbed 6.73% after hours to $1.42 following its public offering and strategic updates.
New Number One Copper Start Alert - Ad
EVs and AI devour copper. Supply cannot keep up. A Quebec discovery with high grade, infrastructure, and cheap power is funded to drill through the year. Catalysts are lining up. Institutions are circling. Move now while it is still early.
Layoffs are piling up, raising worker anxiety. Here are some companies that have cut jobs recently
NEW YORK (AP) — It’s a tough time for the .
Why Is BTQ Technologies Stock Up Today?
Shares of BTQ Technologies Corp. (NASDAQ:BTQ) are rising Thursday after the company announced that it reached a significant technological milestone.
Central Banks Are Buying More Gold Than Ever-And This U.S. Miner Is Ready to Oblige - Ad
Central banks are rapidly increasing their gold reserves-now nearly 20% of global assets. With rising demand and geopolitical pressure, U.S. gold supply is becoming more strategic than ever.
Magnolia Oil & Gas Gets Upgrade On Strong Finances, Brighter Oil Outlook
KeyBanc raised Magnolia Oil & Gas to Overweight with a $29 target, citing a defensive profile and disciplined growth outlook.
Tesla, Palantir JPMorgan And More — Here's Why Investors Couldn't Stop Talking About These Stocks This Week
Retail investors buzzed about five stocks this week, from Oct. 13 to Oct. 17 on X and Reddit's r/WallStreetBets: TSLA, RGTI, OKLO, JPM, PLTR
Why Are 21 Billionaires Moving Their Money ASAP? - Ad
One of the biggest stock market events in 25 years is rapidly unfolding... The economist who predicted the 2008 Financial Crisis says it will be: "The Biggest Crash of Our Lifetime." Starting November 19 it could cut the entire tech marketing by HALF.
LKQ Corp Reveals German Solar Power Partnership
LKQ shares rose after it announced a 20-year solar power deal in Germany, advancing its sustainability and emissions goals.
Meta Lures Gen Z Talent With Six-Figure Salaries Amid Shrinking Job Opportunities — Here's How Much It's Offering
Meta is reportedly offering hefty paychecks for entry-level software engineering roles, a move seen as a response to the challenging job market for recent graduates.
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
Vietnam’s love affair with gas bikes is colliding with a new electric reality
HANOI, Vietnam (AP) — Vietnam is split between two visions: the rumbling, reliable gas-powered motorbikes that now rule the roads, and sleek, silent electric bikes the government says are its future.
XRP Down 4%: Why $2.30 Is The Last Defense Before A Flush To $1.60
XRP (CRYPTO: XRP) is down 4% to $2.39 on Wednesday as traders brace for a potential breakdown below $2.30 — the final support before a deeper retracement that could erase months of gains.
Urgent Copper Stock With Strong Catalysts - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Golf Icon Phil Mickelson Refutes Claims Of Insider Trading Involvement, Says, 'I Make No Trades Whatsoever'
Golfer Phil Mickelson has denied allegations of insider trading linked to an offshore oil company Sable Offshore Corp.
Krispy Kreme (DNUT) Stock Is Surging Wednesday: What's Going On?
Shares of Krispy Kreme are surging Wednesday, lifted by a wave of renewed retail investor interest in meme stocks.
From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.
3 Communication Stocks Making Big Moves On Value Metrics
Three communication service stocks posted sharp gains in Benzinga's value rankings this week, highlighting renewed investor interest in the sector. Here's what investors need to know.
TotalEnergies Profit Outlook Brightens On Refining Strength
TotalEnergies (NYSE: TTE) expects 3Q25 performance to improve with 4% Y/Y increase in oil & gas production.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Trump's White House Bathroom Renovation Sparks Fury, Economist Slams 'Clearly Wrong' Inflation Data And More: This Week In Economy
Week economy roundup: From inflation debates and White House renovations to job declines, stock surges, and Fed rate cuts.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.